Clean Break: the company completely halting Russian engagements or exiting Russia

Leave Withdrawal

The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.

 

Clean Break: the company completely halting Russian engagements or exiting Russia

Leave Withdrawal
Revenue(RF), mln.USD
0
Assets(RF), mln.USD
27
Capital(RF), mln.USD
27
Glob.Revenue, mln.USD
45006
Staff(RF), 2021
123
Taxes(RF), mln.USD
26

The Russian Ministry of Health has revoked the state registration of two anti-tumor drugs used to treat various types of blood cancer: Revlimid and Imnovid. The rights to both drugs belong to the American pharmaceutical company Bristol-Myers Squibb (BMS), which left the Russian market after the war began.

The Company Statement
June 02, 2022

BMS is handing over its Russian commercial operations to its distribution partner Swixx Healthcare, previously known as Amicus, a Bristol spokesperson said over email

Open the Statement
Statements Archive
April 21, 2025Russians left without two American cancer drugs
June 01, 2022Bristol-Myers Squibb is first foreign pharma to leave Russia
May 19, 2022American pharmaceutical giant Bristol-Myers Squibb is leaving Russia
March 15, 2022Novartis, Eli Lilly and AbbVie join growing list of Big Pharmas severing ties with Russia
Share the Company Status:
All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.
Company statements and statistical data are collected from open sources and official registers according to the methodology of the KSE Institute.
Scanner